Geochemist Kevin Rosso earns the highest scientific and leadership honor bestowed by PNNL.

Scientists plumbed the depths of nearly 3,000 soil samples from around the globe to compile the heftiest atlas of soil viruses ever created.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

An energy expert and economist who has played a leading role in formulating and coordinating U.S. climate policy is the new director of the Joint Global Change Research Institute in College Park, Maryland.

PNNL is collaborating with Microsoft, Micron and other partners to make computational chemistry broadly available.

A new method to convert waste plastic to fuel and raw materials promises to help close the carbon cycle at mild temperature and with high yield.

PNNL scientists carve a path to profit from carbon capture by creating a system that efficiently captures CO2 and converts it into one of the world’s most widely used chemicals: methanol.

PNNL will demonstrate how new technologies, innovative approaches and partnering with others can lead to net-zero emissions and decarbonization of operations.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

Through the Net Zero World Initiative, expertise from DOE national laboratories will be harnessed to put global net zero within reach.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Fundamental research conducted at the $90-million research facility will help the nation meet its clean energy goals.

PNNL researchers can make methane from captured CO2 and renewably sourced hydrogen, offering a path toward cheaper synthetic natural gas.

A new report finds small modular reactors could provide competitively priced electricity in Washington state's future electricity market.

PNNL’s newest solvent captures carbon dioxide from power plants for as little as $47.10 per metric ton, marking a significant milestone in the journey to lower the cost of carbon capture.

Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.

A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.

The researchers treated human pancreatic islets with substances produced by the body and thought to be involved in the diabetes disease process.

PNNL tools that track underground contaminants and speed carbon capture technology development are among R&D Magazine's 100 most innovative scientific breakthroughs of the year.